Immunotherapy (APC8015, provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial

Patrick A. Burch, Gary A. Croghan, Dennis A. Gastineau, Lori A. Jones, Judith S. Kaur, Jelle W. Kylstra, Ronald L. Richardson, Frank H. Valone, Stanimir Vuk-Pavlović

Research output: Contribution to journal › Article › peer-review

166 Scopus citations

Fingerprint

Dive into the research topics of 'Immunotherapy (APC8015, provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences